(Q34353016)

1 August 2017

1 reference

title

Anaphylatoxins and infectious and non-infectious inflammatory diseases (English)

1 reference

1 August 2017

Köhl J

1

1 reference

1 August 2017

publication date

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

38

1 reference

1 August 2017

issue

2-3

1 reference

1 August 2017

page(s)

175-187

1 reference

A new paradigm of T cell allergy: requirement for the B-1 cell subset

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Gram-negative sepsis: a dilemma of modern medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Neurogenic amplification of immune complex inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Selective suppression of IL-12 production by chemoattractants

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Protective effects of C5a blockade in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Critical protective role of mast cells in a model of acute septic peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

C5a-induced expression of P-selectin in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

C5A anaphylatoxin and its seven transmembrane-segment receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

1 reference

7 January 2021

The C5a chemoattractant receptor mediates mucosal defence to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Role of C5a in multiorgan failure during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Protective effects of anti-C5a peptide antibodies in experimental sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

A role for the C3a anaphylatoxin receptor in the effector phase of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Different modes of pathogenesis in T-cell-dependent autoimmunity: clues from two TCR transgenic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Requirement and role of C5a in acute lung inflammatory injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? a review and a theoretical framework

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Characterization of synthetic C3a analog peptides on human eosinophils in comparison to the native complement component C3a

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Systemic lupus erythematosus, complement deficiency, and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Impaired mast cell-dependent natural immunity in complement C3-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Selective suppression of interleukin-12 induction after macrophage receptor ligation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: a possible initiating role of B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Activated human T lymphocytes express a functional C3a receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

Augmentation of reverse arthus reaction by mast cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900041-4

7 January 2021

10.1016/S0161-5890(01)00041-4

Identifiers

DOI

1 reference

1 August 2017

1 reference